Tigecycline Adco 50 mg Sterile powder for solution for intravenous infusion
PDF Leaflet Revision Date: 09 May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Severe life-threatening infections in adults.
Dosage (summary)
Initial 100 mg IV, then 50 mg every 12 hours.
Onset of Action / Duration
Onset: Not specified, Duration: 5-14 days.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly population
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Warfarin
- Digoxin
- Oral contraceptives
Contraindications
- Hypersensitivity to tigecycline
- Pregnancy
- Breastfeeding
Common side effects
- Nausea
- Vomiting
- Dizziness
Counselling Points
- Monitor for superinfection
- Avoid in pregnancy and breastfeeding
- Report any severe side effects
Serious warnings
- Higher mortality in some studies
- Anaphylaxis
- Hepatic failure
Important Disclaimer
The Tigecycline Adco 50 mg Sterile powder for solution for intravenous infusion professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
